Floatz logo

Therapeutic Asset Ratings

548 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Toripalimab
Advanced Solid Tumor
Nanjing Immunophage Biotech Co., LtdP2B (63)
Cyclophosphamide
Advanced Solid Tumor
National Cancer Institute (NCI)P3B (62)
Pyrotinib
Advanced Solid Tumor
LaNova Medicines LimitedP3B (61)
Pembrolizumab
Advanced Solid Tumor
InSilico Medicine Hong Kong LimitedP4B (60)
Epirubicin
Advanced Solid Tumor
InSilico Medicine Hong Kong LimitedP3B (60)
rc48-adc
Advanced Solid Tumor
LaNova Medicines LimitedP3B (60)
Tislelizumab
Advanced Solid Tumor
LaNova Medicines LimitedP3B (60)
LENVATINIB
Advanced Solid Tumor
LaNova Medicines LimitedP2B (60)
Inno-206
Advanced Solid Tumor
AstraZenecaP3B (59)
Lurbinectedin
Advanced Solid Tumor
Jazz PharmaceuticalsP2B (59)
Atezolizumab
Advanced Solid Tumor
ExelixisP3B (58)
FULVESTRANT
Advanced Solid Tumor
BeOne MedicinesP3B (58)
Letrozole
Advanced Solid Tumor
Barbara Ann Karmanos Cancer InstituteP3B (58)
Pucotenlimab
Advanced Solid Tumor
Taizhou Hanzhong biomedical co. LTDP3B (58)
TRASTUZUMAB
Advanced Solid Tumor
OnKure, Inc.P3B (58)
Rapamycin
Advanced Solid Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.P2B (58)
Enzalutamide
Advanced Solid Tumor
ExelixisP3B (56)
Metformin
Advanced Solid Tumor
PMV Pharmaceuticals, IncP3B (56)
Catequentinib
Advanced Solid Tumor
Lei LiP2/3B (56)
Abiraterone Acetate
Advanced Solid Tumor
ExelixisP3CCC (55)
Antibody drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE
Advanced Solid Tumor
LaNova Australia Pty LimitedP1/2CCC (55)
Tinengotinib
Advanced Solid Tumor
TransThera Sciences (Nanjing), Inc.P1/2CCC (55)
Iscar Quercus
Advanced Solid Tumor
University Hospital, Basel, SwitzerlandP4CCC (54)
Gotistobart
Advanced Solid Tumor
OncoC4, Inc.P3CCC (54)
Wellbutrin
Advanced Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.P3CCC (54)
Showing 1 to 25 of 548 assets
PreviousPage 1 of 22Next